Ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis - Sorbonne Université
Journal Articles European Respiratory Review Year : 2021

Ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis

Abstract

Cystic fibrosis, due to the absence or abnormal function of the cystic fibrosis transmembrane conductance regulator, is the most common life-limiting autosomal recessive genetic disorder among the Caucasian population. The lungs are particularly affected due to thick and tenacious mucus causing parenchymal anomalies ranging from bronchiectasis, progressive airflow limitation, respiratory infections, lung destruction and ultimately respiratory failure. Despite the remarkable advances in treatment that have greatly improved survival, most patients experience progressive exercise curtailment, with the consequence that a growing number of patients with cystic fibrosis will be referred for exercise-based evaluations in the forthcoming years. Cardiopulmonary exercise testing, in particular, is a useful tool to assess the mechanisms of exercise intolerance in individual patients that may have treatment and prognostic implications. In this review, we will focus on ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis.
Fichier principal
Vignette du fichier
200395.full.pdf (372.68 Ko) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03465142 , version 1 (03-12-2021)

Identifiers

Cite

Pierantonio Laveneziana, Paolo Palange. Ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis. European Respiratory Review, 2021, 30 (162), pp.200395. ⟨10.1183/16000617.0395-2020⟩. ⟨hal-03465142⟩
33 View
21 Download

Altmetric

Share

More